Scott A. Edwards

Internal Medicine
801 Spruce St
Philadelphia, PA 19107

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

The Safety and Biological Activity of OTT166, a Novel Topical Selective Integrin Inhibitor for the Treatment of Diabetic Eye Disease: A Phase 1b Study.

The Safety and Biological Activity of OTT166, a Novel Topical Selective Integrin Inhibitor for the Treatment of Diabetic Eye Disease: A Phase 1b Study.

Journal: Ophthalmic surgery, lasers & imaging retina
Published: October 14, 2022
Showing 1-1 of 1

Last Updated: 09/26/2026